All intelligent investing is value investing – acquiring more than you are paying for.

Investor Portal

What we offer

Reasons to invest

  • Addressing areas of high unmet medical need:
    • Immuno-OncologyPrimary focus on advanced gastrointestinal tumors without surgical option
    • Vaccination: For protection against newly emerging or re-emerging infectious diseases

Markets

Targeting largest drug market segments
Immuno-Oncology market drivers
  • Cancer remains a global burden with increasing number of cancer-related deaths
  • Focus on innovative treatments that reduce reappearance of cancer
  • Clinical success of immunotherapeutics induced paradigm shift in cancer therapy
Vaccine market drivers
  • Increasing global supply causes escalating demand for vaccines
  • Start of governmental vaccination programs to eradicate endemic diseases
  • Launch of novel and innovative vaccine technologies
Global Immuno-Oncology market expectation
Global Vaccine market expectation
bn USD by 2026
0
CAGR
0 %
bn USD by 2026
0
CAGR
0 %

Favourable Risk Profile

Contact

If you are interested in investing in CanVirex AG or would like to receive more information on our products and technology, please get in touch with us.